Core Viewpoint - Altria offers a high dividend yield of 7%, significantly above the S&P 500 average of 1.3%, but faces growth challenges and modest dividend increases, while Eli Lilly provides a lower yield of less than 1% but has shown impressive dividend growth [1][2]. Group 1: Dividend Performance - Altria has raised its dividend for 55 consecutive years, while Eli Lilly's streak began in 2015, indicating a longer history for Altria but not necessarily better growth potential [2]. - In the past five years, Altria's dividend has increased by just over 21%, whereas Eli Lilly's dividends have doubled, showcasing a stark difference in growth rates [4]. Group 2: Stock Performance and Valuation - Eli Lilly's stock has surged by 476% over the past five years, compared to Altria's 52% increase, which lags behind the S&P 500's more than 116% return [5]. - The high performance of Eli Lilly's stock has led to a lower yield, as the stock becomes more expensive relative to its dividend payouts [5]. Group 3: Future Growth Potential - Eli Lilly is experiencing significant growth, particularly in the GLP-1 weight loss market, while Altria faces uncertainty due to declining tobacco use [6]. - Long-term investors may find Eli Lilly to be a better dividend stock despite its current lower yield, as Altria risks potential dividend cuts if profits decline [7][9]. Group 4: Market Outlook - Eli Lilly's elevated valuation may limit future returns, but if returns moderate and the company continues to increase dividends, its yield could rise, making it an attractive long-term investment [8].

Group 1: Company Performance - Imperial Tobacco Group PLC (IMBBY) has returned approximately 15.8% year-to-date, outperforming the average gain of about 7% in the Consumer Staples sector [4] - The Zacks Consensus Estimate for IMBBY's full-year earnings has increased by 2% over the past three months, indicating improving analyst sentiment [3] - In comparison to its industry, Imperial Tobacco is slightly underperforming, as the Tobacco industry has gained about 23.4% year-to-date [5] Group 2: Industry Context - The Consumer Staples sector includes 177 individual stocks and currently holds a Zacks Sector Rank of 14 out of 16 groups [2] - The Tobacco industry, which includes 6 companies, is ranked 169 in the Zacks Industry Rank [5] - Another stock in the Consumer Staples sector, WK Kellogg (KLG), has returned 10.8% year-to-date and has a Zacks Rank of 2 (Buy) [4][5]

Group 1: Market Overview - The end of Q1 2025 is approaching, with many S&P 500 stocks showing strong year-to-date performances despite recent volatility from tariff discussions and economic developments [1] - Notable top performers include Philip Morris (PM), CVS Health (CVS), and Newmont (NEM) [1] Group 2: Philip Morris (PM) - Philip Morris has reported better-than-expected results, with EPS growing by 14% and sales increasing by 7% [2] - Smoke-free products exceeded 40 billion units for the first time in FY24, with net revenues for the Smoke-free Business (SFB) rising by 14.2% and gross profit increasing by 18.7% [3] - The company offers a high dividend yield of 3.5% annually and is recognized as a Dividend King [3] Group 3: CVS Health (CVS) - CVS shares have rebounded significantly in 2025, up 50% year-to-date, ending a prolonged decline [5] - The company experienced a 4% year-over-year sales increase, although EPS declined by 44% [5] - Analysts are optimistic about upcoming quarterly results, with a consensus EPS estimate of $1.62 per share, reflecting a 12% increase and 23% year-over-year growth [7] Group 4: Newmont (NEM) - Newmont, a major gold producer, has seen its stock rise nearly 30% year-to-date, driven by a surge in gold prices [8] - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year [9] - The company reported a record free cash flow of $1.6 billion, enhancing its ability to pay dividends and reduce debt [9][13]

Core Viewpoint - The article highlights three companies—Altria, Verizon, and Chubb Limited—that are considered insulated from the impact of tariffs proposed by the Trump administration, making them attractive investment options in an unpredictable market [1][2]. Group 1: Altria - Altria is the largest tobacco company in America, controlling 45.9% of the U.S. retail cigarette market in 2024, and has diversified into smokeless products [4][6]. - Despite declining adult smoking rates, Altria has managed to maintain profitability through price increases, cost-cutting, and share buybacks, with analysts projecting a 4% EPS growth in 2025 and 3% in 2026 [5][6]. - The stock trades at 11 times forward earnings and offers a forward dividend yield of 7.1%, having raised its payout annually since 2008, making it appealing to income-oriented investors [6][7]. Group 2: Verizon - Verizon is a major telecom company that generates most of its profits from domestic wireless and wireline services, making it less vulnerable to tariffs [8]. - In 2024, Verizon saw a significant recovery, more than doubling its postpaid phone net additions and reducing its total wireless churn rate to 1.62%, attributed to localized marketing and customizable plans [9]. - Analysts expect Verizon's adjusted EPS to grow by 2% in 2025 and 4% in 2026, with the stock trading at 9 times forward earnings and a forward yield of 6.1%, having raised its payout for 18 consecutive years [10]. Group 3: Chubb Limited - Chubb is the largest publicly traded provider of various insurance policies, which are not directly affected by tariffs, as insurance companies do not engage in import/export activities [11]. - Chubb's core operating income per share rose by 30% in 2023 and 13% in 2024, with consolidated net premiums increasing by 13.5% in 2023 and 8.7% in 2024 [12]. - The stock trades at 14 times forward earnings, offers a forward dividend yield of 1.2%, and has raised its payout for 32 consecutive years, making it a stable investment option [13].

Core Viewpoint - Altria's stock price has appreciated by 43.48% since early 2024, driven by a bullish thesis based on two core arguments [1]. Group 1: Stock Performance - The stock price increase of 43.48% occurred before any dividends were accounted for [1]. Group 2: Investment Thesis - The bullish thesis on Altria is based on two main arguments, although the specific arguments are not detailed in the provided text [1].

Core Insights - Altria is facing significant challenges as cigarette demand declines, which is its primary revenue source, while management emphasizes potential opportunities that may indicate the company is lagging behind [1][10] Business Overview - Altria's main business revolves around cigarette sales, which constituted 88% of its revenues in 2024, with cigarettes making up nearly 98% of smokeable tobacco volumes [2] Financial Performance - Cigarette volumes have been declining for years, with a notable drop of 10.2% in 2024; however, price increases have mitigated revenue losses, resulting in a 1.3% revenue decline and a 3.4% rise in adjusted earnings [3] - The company raised its dividend in 2024, reflecting a high dividend yield of approximately 7%, which attracts dividend investors despite the negative trends in its core business [4] Market Trends - The number of smokers in the U.S. decreased from 34 million in 2019 to 28 million in 2024, while non-combustible product users remained stable at around 8 million; however, non-combustible-only consumers surged from 11 million to 18 million, marking a 60% growth [5][6] Strategic Missteps - Altria has made several strategic errors, including spinning off Philip Morris International, which left it vulnerable in a declining cigarette market and created new competition in the non-combustible space [7] - Investments in Juul and a marijuana company resulted in significant write-offs, and while the recent acquisition of NJOY shows better sales performance, it faces patent litigation with Juul [8] Growth Opportunities - Non-combustible products are increasingly important, yet Altria has not capitalized on this trend, with non-smokeable products accounting for only 11.7% of revenues in 2024, down from 12.4% in 2019, despite the non-combustible category growing significantly [9][10]

Core Insights - Investing in "sin stocks," which include companies in alcohol, tobacco, and gambling, has historically provided attractive returns despite ethical concerns due to strong cash flows and loyal customer bases [1][7] Industry Overview - Sin stocks tend to perform well in both economic booms and downturns, benefiting from stable demand, strong pricing power, and consistent dividend payouts [2] - The U.S. alcoholic beverages market is projected to grow from $543.13 billion in 2024 to $806.44 billion by 2033, with a CAGR of 4.99% [4] - The global tobacco market is expected to grow from $899.9 billion in 2024 to $1,157.8 billion by 2032, achieving a CAGR of 3.2% from 2025 to 2032 [5] - The North America online gambling market was valued at $16.56 billion in 2024 and is projected to expand at a CAGR of 12.2% from 2025 to 2030 [6] Company Highlights - Altria Group (MO) dominates the tobacco industry with strong dividends due to its market presence and pricing strategy [3] - Las Vegas Sands (LVS) is positioned as a leader in the gambling sector, benefiting from the acceleration of sports betting legalization and online gaming expansion [3] - Molson Coors Beverage Company (TAP) is transforming its business to align with evolving consumer preferences, focusing on premiumization and innovation [9][10] - Wynn Resorts (WYNN) is enhancing its luxury hospitality offerings and expanding into high-growth markets, including a significant project in the UAE [12][13] - Philip Morris International Inc. (PM) is leading the industry toward a smoke-free future by expanding its smoke-free product portfolio and maintaining strong financial performance [15][16]

Core Viewpoint - Altria is a reliable dividend-paying company with a long history of increasing its per-share payout, making it an attractive option for dividend income investors [1][2]. Dividend Performance - Altria has consistently paid dividends every quarter for decades and has raised its quarterly dividend payment for 55 consecutive years, with some years seeing two increases [1][2]. - The current quarterly dividend payment is $1.02 per share, and to achieve $1,000 in dividend income by 2025, an investor would need to own 245 shares, subject to potential changes in the dividend rate [2]. - The average yearly growth in Altria's quarterly dividend since 1989 has been over 6.5%, with the most recent increase being just under 4.1% [3]. Business Outlook - Altria, which owns popular U.S. cigarette brands like Marlboro and Virginia Slims, acknowledges the challenges posed by the global smoking-cessation movement and modest demand for smokeless alternatives [4]. - Despite potential future challenges, the company is expected to maintain its dividend payments for the foreseeable future, supported by population growth and a solid forward-looking dividend yield of 7.1% [5].

Company Performance - Altria's stock closed at $56.71, reflecting a -1.63% change from the previous day's closing price, underperforming the S&P 500 which gained 0.16% [1] - Over the past month, Altria's shares increased by 4.34%, outperforming the Consumer Staples sector which saw a loss of 0.69% and the S&P 500's loss of 3.59% [2] Upcoming Earnings - Altria is expected to report an EPS of $1.19, representing a 3.48% increase compared to the same quarter last year, with a revenue forecast of $4.66 billion, indicating a 1.11% decrease from the same quarter last year [3] - For the entire fiscal year, earnings are projected at $5.32 per share and revenue at $20.48 billion, reflecting changes of +3.91% and +0.18% respectively from the prior year [4] Analyst Estimates and Rankings - Recent changes in analyst estimates for Altria are crucial as they indicate evolving short-term business trends, with positive revisions suggesting analyst optimism regarding the company's profitability [4] - The Zacks Rank system, which includes estimate changes, currently ranks Altria at 3 (Hold), with the consensus EPS estimate remaining unchanged over the past month [6] Valuation Metrics - Altria has a Forward P/E ratio of 10.84, which is in line with the industry average, and a PEG ratio of 3.07, compared to the tobacco industry average PEG ratio of 2.82 [7] Industry Context - The Tobacco industry, part of the Consumer Staples sector, holds a Zacks Industry Rank of 78, placing it in the top 32% of over 250 industries, indicating strong performance potential [8]

Core Viewpoint - Altria Group, Inc. has shown strong performance in the tobacco industry, rising 5.1% over the past month, significantly outperforming the Zacks Tobacco industry's growth of 0.9% and the broader market declines [1][2][20] Stock Performance - Altria's stock closed at $57.65, only 3.4% below its 52-week high of $59.67, and reflects a 41.8% premium over its 52-week low of $40.65 [5] - The stock is trading above both its 50-day and 200-day moving averages, indicating bullish market sentiment [5][6] Competitive Position - Altria has outperformed key competitors such as Philip Morris International, which declined by 2.1%, and Turning Point Brands, which dropped by 14.4% [2] - British American Tobacco matched Altria's performance with a 5.1% gain over the same period [2] Strategic Initiatives - Altria is focusing on a smoke-free future, emphasizing harm reduction and innovative alternatives for adult smokers [10] - The NJOY brand has expanded its distribution to over 100,000 stores, achieving a 15% increase in consumable shipments, totaling 12.8 million units in the fourth quarter [11] - The on! brand, a tobacco-derived nicotine pouch, saw a 44% year-over-year growth in shipment volume, reaching nearly 44 million cans [12] - The "Optimize and Accelerate" initiative aims to modernize operations and achieve cost savings while maintaining pricing strength [13] Valuation - Altria is trading at a forward 12-month P/E of 10.74X, below the industry average of 13.80X, suggesting potential for upside as the company executes its growth strategy [14] Market Challenges - The e-vapor market is facing challenges from illicit flavored disposable products, which account for over 60% of the category, complicating Altria's efforts in the compliant e-vapor segment [17] - Domestic cigarette shipment volumes declined by 8.8% in the fourth quarter, reflecting broader industry challenges and retail share losses [18][19] Investment Outlook - Despite challenges, Altria's solid fundamentals and growth in the e-vapor market position the company for long-term success [20] - The stock appears undervalued compared to peers, presenting an attractive opportunity for long-term investors [21]